Network with Captive Review on LinkedIn

Follow Captive Review on Twitter

RSS

4th of February 2012

Solvency II to boost reinsurance use

Gavin Bradshaw 02/07/2010

Solvency II will boost the importance of reinsurance to captive and other insurance programmes, according to a new report launched this week.
 
The 63-page study by Aon Benfield. Solvency II for Reinsurance Managers, said Solvency II will prove the value of reinsurance as an efficient form of capital.
 
However, the report stressed that partial internal models are crucial to obtaining a more accurate picture of premium risk.
 
“In a Solvency II world, reinsurance is the most obvious place to start with an internal model,” said Marc Beckers, head of EMEA Analytics at Aon Benfield [pictured above].
 
“Under the current proposal, the benefit of an internal model compared to the Standard Formula is largest for reinsurance, particularly for non-proportional property cat and casualty reinsurance.”
 
The report argues that the Standard Formula does not provide adequate credit for non-proportional reinsurance on casualty lines.
 
In particular, it said, the existing proposal in QIS 5 penalises larger insurers by providing no noticeable benefit from purchasing non-proportional reinsurance.
 
The study went on to say that as regulation puts further pressure on capital, buying reinsurance should no longer be a budget matter, but should be based on sound risk and capital considerations. 
 
“Rather than looking to raise capital to fund any shortfall in net assets, companies may consider reinsurance options to reduce their capital requirement,” said Beckers.
 
“Furthermore, volatility of earnings will increase as a result of fair value accounting (Solvency II and IFRS Phase II) and reinsurance is the cheapest and most efficient way to reduce this volatility.”

Tags: Aon Benfield, Reinsurance, Solvency II

Post a comment

Post a comment

Be the first to comment on this article!

Captive Insurance Database (CID) is the world's leading and most comprehensive online source of captive market intelligence.

CID gives users instant access to the names of parent companies who currently own a captive. It also gives you the captive name, manager, license date and the type of captive the parent company are running. Uniquely CID also contains vital contact information on captive owners and sponsors. This can be used to chase after new business or simply to get a better grasp of the market 

CID will start helping you in,

•    Winning more business proactively – Search from 5,292 captives and over 3,000 captive owners who you can offer your services to.
•    Increasing profit and efficiency – Target specific captive owners and sponsors quicker, saving you time.
•    Building relationships – Detailed contact information for each decision-maker 

An annual CID license costs just £1,195 + VAT.

Already a CID user? LOGIN to the database here.

Order a 2 year subscription and SAVE 25%
The license includes full online access to CID and a free annual hardcopy of CID (worth £610) . To find out more contact Ryan Nash on +44 (0) 20 7029 4065 or
r.nash@pageantmedia.com

more//

Company and Ratings Search

Search A.M. Best's extensive database of life/health, property/casualty and insurance companies worldwide.

more//

Cell Company Guide

WELCOME TO THE Captive Review Cell Company Handbook 2009 – the second edition of our global directory of cell company jurisdictions. Since we last published this directory, the general attitude toward cell companies seems to have shifted up a gear. Whereas single-parent companies have long ruled the captive roost, a slight uptick in the formation of pure captives at the beginning of this year can’t hide the fact that growth in this market is still sluggish.

more//

Pellentesque feugiat arcu vitae lacus elementum in ullamcorper diam pulvinar. In odio massa, facilisis sed dignissim vel, vehicula ac diam. Curabitur tempor, quam nec aliquam tempus, dui lorem venenatis arcu

Mauris accumsan orci ut turpis placerat condimentum. Ut sit amet lobortis purus. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.

CID